Q4 2016
Read transcript →Galectin Therapeutics Inc. (GALT)
NASDAQ·Healthcare·Biotechnology
$2.34
-1.48%
Mkt Cap $215.98M
Q4 2015
Read transcript →NASDAQ·Healthcare·Biotechnology
$2.34
-1.48%
Mkt Cap $215.98M
Q4 2016
Read transcript →Q4 2015
Read transcript →